Home The Word Brain My Amedeo FAQ Privacy About   

As of October 2023, Amedeo had
12,263 active subscribers

  Inflammatory Bowel Diseases

  Free Subscription


1 Aliment Pharmacol Ther
2 BMC Gastroenterol
1 Eur J Gastroenterol Hepatol
1 Gastroenterology
6 Inflamm Bowel Dis
3 J Crohns Colitis
1 Lancet Gastroenterol Hepatol
1 PLoS Med
1 Scand J Gastroenterol

  Retrieve available abstracts of this week’s articles:
HTML format
Single Articles

    Aliment Pharmacol Ther

  1. LENFANT M, Verstockt B, Sabino J, Vermeire S, et al
    The assessment of segmental healing by the Modified Mayo Endoscopic Score (MMES) complements the prediction of long-term clinical outcomes in patients with ulcerative colitis.
    Aliment Pharmacol Ther. 2023 Oct 16. doi: 10.1111/apt.17753.
    PubMed         Abstract available

    BMC Gastroenterol

  2. XU ZY, Wang JC
    LACC1 regulates changes in the intestinal flora in a mouse model of inflammatory bowel disease.
    BMC Gastroenterol. 2023;23:358.
    PubMed         Abstract available

  3. MILO F, Angelino G, Romeo EF, De Angelis P, et al
    Depression symptoms increase the risk for initiation or switching to biologic therapy in pediatric inflammatory bowel disease patients in remission.
    BMC Gastroenterol. 2023;23:355.
    PubMed         Abstract available

    Eur J Gastroenterol Hepatol

  4. LIU C, Liu X, Shi H, Chen F, et al
    The correlation between serum 25-hydroxyvitamin D level and ulcerative colitis: a systematic review and meta-analysis.
    Eur J Gastroenterol Hepatol. 2023 Oct 18. doi: 10.1097/MEG.0000000000002670.
    PubMed         Abstract available


  5. STIDHAM RW, Cai L, Cheng S, Rajaei F, et al
    Using Computer Vision to Improve Endoscopic Disease Quantification in Therapeutic Clinical Trials of Ulcerative Colitis.
    Gastroenterology. 2023 Oct 11:S0016-5085(23)05086.
    PubMed         Abstract available

    Inflamm Bowel Dis

  6. DALAL RS, Sharma PP, Bains K, Pruce JC, et al
    Clinical and Endoscopic Outcomes Through 78 Weeks of Tofacitinib Therapy for Ulcerative Colitis in a US Cohort.
    Inflamm Bowel Dis. 2023 Oct 16:izad242. doi: 10.1093.
    PubMed         Abstract available

  7. KRUGLIAK CLEVELAND N, Miyatani Y, Picker EA, Rubin DT, et al
    At-home Disease Monitoring by Patient-performed Intestinal Ultrasound in Severe Ulcerative Colitis.
    Inflamm Bowel Dis. 2023 Oct 16:izad237. doi: 10.1093.

  8. COLLEN LV, Mitsialis V, Kim DY, Bresnahan M, et al
    Efficacy and Safety of Anti-Tumor Necrosis Factor Alpha in Very Early Onset Inflammatory Bowel Disease.
    Inflamm Bowel Dis. 2023 Oct 17:izad196. doi: 10.1093.
    PubMed         Abstract available

  9. PRAKASH P, Dua A, Blumenfeld Y, Chen PH, et al
    Longitudinal Trends in Pregnancy Outcomes Among Women With Inflammatory Bowel Disease in the Era of Biologics: A 20-Year Nationwide Analysis.
    Inflamm Bowel Dis. 2023 Oct 19:izad250. doi: 10.1093.
    PubMed         Abstract available

  10. DONNELLY M, Driever D, Ryan EJ, Elliott JA, et al
    Obesity, Sarcopenia and Myosteatosis: Impact on Clinical Outcomes in the Operative Management of Crohn's Disease.
    Inflamm Bowel Dis. 2023 Oct 20:izad225. doi: 10.1093.
    PubMed         Abstract available

  11. DIMOPOULOS-VERMA A, Hong S, Axelrad JE
    Enteric Infection at Flare of Inflammatory Bowel Disease Impacts Outcomes at 2 Years.
    Inflamm Bowel Dis. 2023 Oct 20:izad253. doi: 10.1093.
    PubMed         Abstract available

    J Crohns Colitis

  12. MULLER M, Broseus J, Guilloteau A, Wasse S, et al
    Lymphoma In Patients With Inflammatory Bowel Disease: A Multicenter Collaborative Study Between Getaid And Lysa.
    J Crohns Colitis. 2023 Oct 18:jjad177. doi: 10.1093.
    PubMed         Abstract available

  13. ALIBERT L, Betton L, Falcoz A, Manceau G, et al
    Does KONO-S anastomosis reduce recurrence in Crohn's disease compared to conventional ileocolonic anastomosis? A nationwide propensity score-matched study from GETAID Chirurgie Group (KoCoRICCO study).
    J Crohns Colitis. 2023 Oct 18:jjad176. doi: 10.1093.
    PubMed         Abstract available

  14. ROBLIN X, Paul S
    Adalimumab: A 'Maillon Faible' in the Treatment of Ulcerative Colitis?
    J Crohns Colitis. 2023 Oct 17:jjad167. doi: 10.1093.

    Lancet Gastroenterol Hepatol

  15. PATHIYIL MM, Jena A, Venkataramana Raju AK, Omprakash TA, et al
    Representation and reporting of diverse groups in randomised controlled trials of pharmacological agents in inflammatory bowel disease: a systematic review.
    Lancet Gastroenterol Hepatol. 2023 Oct 10:S2468-1253(23)00193.
    PubMed         Abstract available

    PLoS Med

  16. SUN J, Roelstraete B, Svennberg E, Halfvarson J, et al
    Long-term risk of arrhythmias in patients with inflammatory bowel disease: A population-based, sibling-controlled cohort study.
    PLoS Med. 2023;20:e1004305.
    PubMed         Abstract available

    Scand J Gastroenterol

  17. YAN Q, Feng Z, Jiang B, Yao J, et al
    Biological functions of connexins in the development of inflammatory bowel disease.
    Scand J Gastroenterol. 2023 Oct 14:1-8. doi: 10.1080/00365521.2023.2267713.
    PubMed         Abstract available

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge.